Home / BusinessBusinessBloombergBusinessBloomberg·Sep 15, 2026·1 min readBig Pharma Needs New Drugs. China Has ThemBig Pharma is betting on China for its next blockbuster drugs — what that shift means for patients and the future of US biotech dominance. (Source: Bloomberg)View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesHealthSouth China Morning PostHealthSep 9, 2026 · 1 minChina needs monkeys: lab animal shortage could hinder biotech growthSouth China Morning PostWorldSouth China Morning PostWorldJun 7, 2026 · 1 minWhich company could become the Chinese Pfizer? Here are analysts’ top picksSouth China Morning PostHealthCNBCHealthJun 16, 2026 · 1 minBiotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBCCNBCTechnologySouth China Morning PostTechnologySep 9, 2026 · 1 minAs China embraces AI, only 24% of US pharma execs bet on it for drug-makingSouth China Morning Post
HealthSouth China Morning PostHealthSep 9, 2026 · 1 minChina needs monkeys: lab animal shortage could hinder biotech growthSouth China Morning Post
WorldSouth China Morning PostWorldJun 7, 2026 · 1 minWhich company could become the Chinese Pfizer? Here are analysts’ top picksSouth China Morning Post
HealthCNBCHealthJun 16, 2026 · 1 minBiotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBCCNBC
TechnologySouth China Morning PostTechnologySep 9, 2026 · 1 minAs China embraces AI, only 24% of US pharma execs bet on it for drug-makingSouth China Morning Post